Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-14

Clinical Trial Update: Effects of Dexmedetomidine on Postoperative Neurocognitive Disorder

View source ↗

Summary

A clinical trial evaluating the effects of dexmedetomidine on postoperative neurocognitive disorder is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Neurocognitive Disorder, Dexmedetomidine Infusion | Status: ACTIVE_NOT_RECRUITING